VHLD Vector 21 Holdings Inc (PK)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2024

 

OR

 

☐ TRANSACTION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ________ to _________

 

Commission file number: 000-56418

 

VECTOR 21 HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

 

Delaware		88-1065560
State or other jurisdiction of incorporation or organization		(I.R.S. Employer Identification No.)
12136 West Bayaud Avenue, Suite 300 Lakewood, CO		80228
(Address of principal executive offices)		(Zip Code)

 

303-422-8127

Registrant’s telephone number, including area code

 

__________________________________________

(former name, former address and former fiscal year if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. 

☒ Yes   ☐ No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes    ☐ No

 

Indicate by check mark whether the registrant is a large, accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large, accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large, accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
		Emerging growth company	☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). ☒ Yes     ☐ No

 

As of May 15, 2024, there were 1,697,200 common shares, $0.0001 par value, issued and outstanding.

 

TABLE OF CONTENTS

 

 

 

		Page
PART I – FINANCIAL INFORMATION
Item 1.	Financial Statements	1
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	12
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	19
Item 4.	Controls and Procedures	19
PART II – OTHER INFORMATION
Item 1.	Legal Proceedings	21
Item 1A.	Risk Factors	21
Item 2.	Unregistered Sale of Equity Securities and Use of Proceeds	21
Item 3.	Defaults Upon Senior Securities	21
Item 4.	Mine Safety Disclosures	21
Item 5.	Other Information	21
Item 6.	Exhibits	21
SIGNATURES		22

 

 

PART I

 

Item 1. Financial Statements.

 

VECTOR 21 HOLDINGS, INC.
CONDENSED UNAUDITED BALANCE SHEETS
		MARCH 31, 2024				JUNE 30, 2023
		UNAUDITED				AUDITED
ASSETS
Current Assets
Cash and cash equivalents		$	132			$	325
Total Current Assets			132				325
Total Assets		$	132			$	325
LIABILITIES AND SHAREHOLDERS' DEFICIT
Current Liabilities
Accounts payable and accruals		$	47,183			$	33,912
Loan payable - related party			25,399				7,759
Promissory notes - related parties			51,415				50,380
Total Current Liabilities			123,997				92,051
Total Liabilities			123,997				92,051
Commitments and Contingencies (Note 7)
Shareholders' Deficit
Common stock, $0.0001 par value, 500,000,000 shares authorized, 1,697,200 shares issued and outstanding			170				170
Additional paid in capital			17,673,072				17,673,072
Accumulated Deficit			(17,797,107	)			(17,764,968	)
Total Shareholders' Deficit			(123,865	)			(91,726	)
Total Liabilities and Shareholders' Deficit		$	132			$	325

The accompanying notes are an integral part of these condensed unaudited financial statements.

 

 

 

 

VECTOR 21 HOLDINGS, INC.
CONDENSED UNAUDITED STATEMENTS OF OPERATIONS
		FOR THE THREE MONTHS ENDED MARCH 31								FOR THE NINE MONTHS ENDED MARCH 31
		2024				2023				2024				2023
REVENUE		$	—			$	—			$	—			$	—
OPERATING EXPENSES:
General and administrative expenses			5,462				10,479				31,104				27,537
TOTAL OPERATING EXPENSES			5,462				10,479				31,104				27,537
OPERATING LOSS			(5,462	)			(10,479	)			(31,104	)			(27,537	)
OTHER EXPENSE
Interest expense – related party			(405	)			—				(1,035	)			—
LOSS BEFORE TAXES			(5,867	)			(10,479	)			(32,139	)			(27,537	)
TAXES			—				—				—				—
NET LOSS		$	(5,867	)		$	(10,479	)		$	(32,139	)		$	(27,537	)
Weighted average shares outstanding- basic and diluted			1,697,200				1,697,200				1,697,200				1,697,200
Net loss per share – basic and diluted		$	(0.01	)		$	(0.01	)		$	(0.01	)		$	(0.01	)

The accompanying notes are an integral part of these condensed unaudited financial statements.

 

 

 

 

 

VECTOR 21 HOLDINGS, INC.
CONDENSED UNAUDITED STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT
FOR THE THREE & NINE MONTHS ENDED MARCH 31, 2024 AND 2023
		Common Shares								Additional Paid-in Capital				Accumulated Deficit				Total
		Shares				Amount
THREE MONTHS
Balance at December 31, 2023			1,697,200			$	170			$	17,673,072			$	(17,791,240	)		$	(117,998	)
Net loss for the period			—				—				—				(5,867	)			(5,867	)
Balance at March 31, 2024			1,697,200			$	170			$	17,673,072			$	(17,797,107	)		$	(123,865	)
Balance at December 31, 2022			1,697,200			$	170			$	17,673,072			$	(17,747,757	)		$	(74,515	)
Net loss for the period			—				—				—				(10,479	)			(10,479	)
Balance at March 31, 2023			1,697,200			$	170			$	17,673,072			$	(17,758,236	)		$	(84,994	)
NINE MONTHS
Balance at June 30, 2023			1,697,200			$	170			$	17,673,072			$	(17,764,968	)		$	(91,726	)
Net loss for the period			—				—				—				(32,139	)			(32,139	)
Balance at Mar 31, 2024			1,697,200			$	170			$	17,673,072			$	(17,797,107	)		$	(123,865	)
Balance at June 30, 2022			1,697,200			$	170			$	17,673,072			$	(17,730,699	)		$	(57,457	)
Net loss for the period			—				—				—				(27,537	)			(27,537	)
Balance at March 31, 2023			1,697,200			$	170			$	17,673,072			$	(17,758,236	)		$	(84,994	)

 

The accompanying notes are an integral part of these condensed unaudited financial statements.

 

 

 

 

VECTOR 21 HOLDINGS, INC.
CONDENSED UNAUDITED STATEMENTS OF CASH FLOWS
		FOR THE NINE MONTHS ENDED MARCH 31,
		2024				2023
Cash Flows from Operating Activities:
Net Loss		$	(32,139	)		$	(27,537	)
Changes in working capital items:
Prepaid Expenses			—				4,583
Accounts Payable & Accruals			13,271				7,289
Net Cash Flows Used in Operating Activities			(18,868	)			(15,665	)
Cash Flows from Financing Activities
Loan Payable- Related Party			17,640				9,020
Advances Under Promissory Notes – Related Parties			1,035				7,000
Net Cash Flows from Financing Activities			18,675				16,020
Net increase (decrease) in Cash:		$	(193	)		$	355
Cash, beginning of period:			325				—
Cash, end of period:		$	132			$	355
Supplemental Disclosures of Cash Flow Information:
Cash paid for interest		$	—			$	—
Cash paid for income tax		$	—			$	—
Non-Cash Investing and Financing Activities
Conversion of loan payable - related party to Promissory Note Payable - Related Party			—				41,110

 

The accompanying notes are an integral part of these condensed unaudited financial statements.

VECTOR 21 HOLDINGS, INC.

NOTES TO CONDENSED UNAUDITED FINANCIAL STATEMENTS

FOR THE THREE AND NINE MONTHS ENDED MARCH 31, 2024 AND 2023

 

 

NOTE 1. NATURE OF OPERATIONS

 

Nature of Business

 

Vector 21 Holdings, Inc., a Delaware corporation, (“Vector 21”, “the Company”, “We", "Us" or “Our’) is a publicly quoted shell company seeking to merge with an entity with experienced management and opportunities for growth in return for shares of our common stock to create values for our shareholders. No potential merger candidate has been identified at this time.

 

History

 

Vector 21 was incorporated in Delaware on March 5, 2021.

 

Effective April 28, 2021, following a corporate reorganization as described below (‘the Holding Company Reorganization” or ‘the reverse recapitalization”), Vector 21 became the reorganized successor to Momentum Biofuels, Inc. (“Predecessor Company”), a publicly quoted holding company that ceased trading in 2012.

 

Reorganization into a Holding Company Structure for Vector 21 Holdings, Inc., reorganization successor to Momentum Biofuels, Inc.

 

Effective March 10, 2021, Momentum Biofuels, Inc. (“Momentum Biofuels Colorado”), a Colorado corporation, redomiciled to Delaware by merging with its wholly owned subsidiary, Momentum Biofuels, Inc., a Delaware corporation.

 

Momentum Biofuels Colorado ceased to exist as an independent legal entity following its merger with Momentum Biofuels Delaware.

 

Pursuant to the Delaware Holding Company formation statute, DGCL Section 251(g), Momentum Biofuels Delaware entered into an Agreement and Plan of Merger and Reorganization into a Holding Company with Vector 21 Holdings, Inc. (“Vector 21”) and MBF Ops, Inc. (“MBF Ops.”), both wholly owned subsidiaries of Momentum Biofuels Delaware, effective April 28, 2021.

 

The Agreement and Plan of Merger and Reorganization into a Holding Company provided for the merger of Momentum Biofuels Delaware with, and into MBF Ops., with MBF Ops. being the surviving corporation in the merger, as a subsidiary to Vector 21.

 

Momentum Biofuels Delaware ceased to exist as an independent legal entity following its merger with MBF Ops.

 

The shareholders of Momentum Biofuels Delaware were converted, by the holding company reorganization, under the Agreement, to shareholders of Vector 21 on a one for one basis pursuant to the Agreement and the Delaware Statute Sec. 251(g).

 

MBF Ops., the surviving company of the merger with Momentum Biofuels Delaware, became a wholly owned subsidiary of Vector 21, the holding company.

 

Vector 21 became the parent holding company resulting under the Agreement, pursuant to Delaware General Corporation Law section 251(g), with its wholly owned subsidiary company, MBF Ops, the surviving company of the merger with Momentum Biofuels Delaware.

 

As a result of the Holding Company Reorganization, shareholders in the publicly quoted Momentum Biofuels Delaware, formerly the shareholders of Momentum Biofuels Colorado as of the date of the reorganization, became shareholders in the publicly quoted Vector 21.

 

MBF Ops, being the direct successor by the merger with Momentum Biofuels Delaware, became a subsidiary company of Vector 21.

 

Disposal of MBF Ops.

 

Effective June 28, 2021, Vector 21 disposed of 100% of the issued share capital of its sole subsidiary company, MBF Ops., to an unrelated third party. We made a $1,000 payment in cash and promised to issue 50,000 post-split shares of our common stock to the company (MBF) as capital for the subsidiary company which had no ongoing business or assets and outstanding liabilities of $1,130,842. These shares of common stock have been issued to the Purchaser as of the date of these financial statements.

The Holding Company Reorganization has been accounted for so as to reflect the fact that both Momentum Biofuels Delaware and Vector 21 were under common control at the date of the Holding Company Reorganization.

 

Reverse and Forward Stock Splits

 

Effective May 13, 2021, we completed:

 

-

a reverse stock split of our outstanding common stock, $0.0001 par value, on a one (1) post-split share for eight thousand (8,000) pre-split shares basis, and subsequently

 

-

a forward stock split of our post reverse split outstanding common stock, $0.0001 par value, on a one hundred (100) post-split shares for one (1) pre-split share basis.

 

As a result of the 8,000: 1 reverse stock split described above, the number of issued and outstanding shares of the Company’s common stock was reduced from 123,224,444 to 15,403. No fractional shares were issued in connection with the reverse stock split. Instead, a holder of record of common stock who would otherwise be entitled to a fraction of a share was, in lieu thereof, entitled to receive a whole share of common stock. Consequently 1,069 additional shares were issued in respect of fractional shares and therefore a total of 16,472 shares of common stock were issued and outstanding after the reverse split.

 

As a result of 1:100 forward stock split described above, the number of issued and outstanding shares of the Company’s common stock increased from 16,472 to 1,647,200.

 

A total of 1,697,200 shares of common stock are currently outstanding on the date of the filing.

 

Impact of the Ukrainian and Israeli Conflicts

 

We believe that the conflicts involving Ukraine and Israel do not have any direct impact on our operations, financial condition, or financial reporting.  We believe the conflicts will have only a general impact on our operations in the same manner as it is having a general impact on all businesses that have their operations limited to North America resulting from international sanction and embargo regulations, possible shortages of goods and goods incorporating parts that may be supplied from countries involved in the conflicts, supply chain challenges, and the international and US domestic inflation resulting from the conflict and government spending in relation to the conflicts. As we are a shell company, we do not believe we will be targeted for cyber-attacks related to the conflicts. We have no operations in the countries directly involved in the conflict or are specifically impacted by any of the sanctions and embargoes, as we principally operate solely in the United States. We do not believe that the conflicts will have any impact on our internal control over financial reporting.  Other than general securities market trends, we do not have reason to believe that investors will evaluate the company as having special risks or exposures related to the conflicts.

 

Inflation

 

We anticipate that our business and financial position will be impacted by the current inflationary environment. To the extent that we use borrowed funds, we believe costs will increase for us. Access to capital will be impacted by increased interest rates and may affect our ability to obtain capital. Inflation will also have an impact on the cost of supplies of goods and services that we use with the consequence of an adverse impact on our operating costs.

 

NOTE 2. GOING CONCERN

 

Our financial statements are prepared using accounting principles generally accepted in the United States of America (“GAAP”) applicable to a going concern, which contemplate the realization of assets and the liquidation of liabilities in the normal course of business. We have no ongoing business or income and for the nine-months period ended March 31, 2024 we incurred a loss of $32,139 and had an accumulated deficit of $17,797,107 as of March 31, 2024. These conditions raise substantial doubt about our ability to continue as a going concern. The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the outcome of these uncertainties. Our ability to continue as a going concern is dependent upon our ability to raise additional debt or equity funding to meet our ongoing operating expenses and ultimately in merging with another entity with experienced management and profitable operations. No assurances can be given that we will be successful in achieving these objectives.

 

NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

This summary of significant accounting policies is presented to assist in the understanding of financial statements. These policies conform to GAAP and have been consistently applied. The Company has selected June 30 as its financial year end.

 

Interim Financial Statements

 

The accompanying unaudited interim condensed financial statements have been prepared in accordance with GAAP for interim financial information in accordance with Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The accompanying condensed financial statements have been prepared by the Company without audit. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations, changes in shareholders’ deficit and cash flows as of March 31, 2024 and for the related periods presented, have been included. The results for the three- and nine-months period ended March 31, 2024 are not necessarily indicative of the results of operations for the full year. These financial statements and related footnotes should be read in conjunction with the financial statements and footnotes thereto for the years ended June 30, 2023 and 2022 included in our Form 10-12G/A filed on October 30, 2023.

 

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Cash and Cash Equivalents:

 

We maintain cash balances in a non-interest-bearing account that currently does not exceed federally insured limits. For the purpose of the statements of cash flows, all highly liquid investments with a maturity of three months or less are considered to be cash equivalents. As of March 31, 2024, and June 30, 2023, our cash balances were $132 and $325 respectively.

 

 

Fair Value Measurements:

 

ASC Topic 820, Fair Value Measurements and Disclosures ("ASC 820"), provides a comprehensive framework for measuring fair value and expands disclosures which are required about fair value measurements. Specifically, ASC 820 sets forth a definition of fair value and establishes a hierarchy prioritizing the inputs to valuation techniques, giving the highest priority to quoted prices in active markets for identical assets and liabilities and the lowest priority to unobservable value inputs. ASC 820 defines the hierarchy as follows:

 

Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reported date. The types of assets and liabilities included in Level 1 are highly liquid and actively traded instruments with quoted prices, such as equities listed on the New York Stock Exchange.

 

Level 2 – Pricing inputs are other than quoted prices in active markets but are either directly or indirectly observable as of the reported date. The types of assets and liabilities in Level 2 are typically either comparable to actively traded securities or contracts or priced with models using highly observable inputs.

 

Level 3 – Significant inputs to pricing that are unobservable as of the reporting date. The types of assets and liabilities included in Level 3 are those with inputs requiring significant management judgment or estimation, such as complex and subjective models and forecasts used to determine the fair value of financial transmission rights.

 

Our financial instruments consist of our prepaid expenses, accounts payable and accruals, loan payable- related party and promissory note- related party. The carrying amount of our prepaid expenses, accounts payable and accruals, loan payable- related party and promissory note- related party approximates their fair values because of the short-term maturities of these instruments.

 

Related Party Transactions:

 

A related party is generally defined as (i) any person that holds 10% or more of our membership interests including such person's immediate families, (ii) our management, (iii) someone that directly or indirectly controls, is controlled by or is under common control with us, (iv) any person who is or was (since the beginning of the last fiscal year for which the Company has filed an Annual Report on Form 10-K and proxy statement, even if such person does not presently serve in that role) an executive officer, director or nominee for director of the Company, or (v) anyone who can significantly influence our financial and operating decisions. A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties. See Notes 5 and 6 below for details of related party transactions in the period presented.

 

Leases:

 

We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) as assets, operating lease non-current liabilities, and operating lease current liabilities in our balance sheet. Finance leases are property and equipment, other current liabilities, and other non-current liabilities in the balance sheet.

 

ROU assets represent the right to use an asset for the lease term and lease liability represent the obligation to make lease payment arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over lease term. As most of the leases doesn’t provide an implicit rate. We generally use the incremental borrowing rate on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. The operating ROU asset also includes any lease payments made and excludes lease incentives. Lease expense for lease payment is recognized on a straight-line basis over lease term.

 

The Company was not party to any lease transaction during the three and nine-month periods ended March 31, 2024 and 2023.

 

 

Income Taxes:

 

The provision for income taxes is computed using the asset and liability method, under which deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating losses and tax credit carryforwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates that apply to taxable income in effect for the years in which those tax assets are expected to be realized or settled. We record a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.

 

Uncertain Tax Positions:

 

We evaluate tax positions in a two-step process. We first determine whether it is more likely than not that a tax position will be sustained upon examination, based on the technical merits of the position. If a tax position meets the more-likely-than-not recognition threshold, it is then measured to determine the amount of benefit to recognize in the financial statements. The tax position is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement. We classify gross interest and penalties and unrecognized tax benefits that are not expected to result in payment or receipt of cash within one year as long-term liabilities in the financial statements.

 

Revenue Recognition:

 

Revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:

 

Step 1: Identify the contract(s) with customers.

Step 2: Identify the performance obligations in the contract.

Step 3: Determine the transaction price.

Step 4: Allocate the transaction price to performance obligations.

Step 5: Recognize revenue when the entity satisfies a performance obligation.

 

As the Company had no business operations during the three and nine-month periods ended March 31, 2024 and 2023, we have not identified specific planned revenue streams.

 

During the three and nine-month periods ended March 31, 2024 and 2023, we did not recognize any revenue.

 

Advertising Costs:

 

We expense advertising costs when advertisements occur. No advertising costs were incurred during the three and nine-month periods ended March 31, 2024 and 2023.

 

Stock-Based Compensation:

 

The cost of equity instruments issued to employees and non-employees in return for goods and services is measured by the grant date fair value of the equity instruments issued in accordance with ASC 718, Compensation – Stock Compensation. The related expense is recognized as services are rendered or vesting periods elapse.

 

Net Loss per Share Calculation:

 

Basic earnings (loss) per common share ("EPS") is computed by dividing net income (loss) available to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings (loss) per share is computed by dividing net income (loss) by the weighted average shares outstanding, assuming all dilutive potential common shares were issued. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive. No potentially dilutive debt or equity instruments were issued or outstanding during the three and nine-month periods ended March 31, 2024 and 2023.

 

Recently Accounting Pronouncements:

 

We have reviewed all the recently issued, but not yet effective, accounting pronouncements and do not believe any of these pronouncements will have a material impact on our financial statements.

 

NOTE 4. ACCOUNTS PAYABLE AND ACCRUALS

 

As of March 31, 2024, and June 30, 2023, the balance of accounts payable and accrued expenses was $47,183 and $33,912, respectively.

 

As of March 31, 2024, $35,733 of the balance was due to our share transfer agent, $6,450 related to accounting fees and $5,000 related to audit fees. As of June 30, 2023, $29,262 of the balance was due to our share transfer agent and $4,650 related to accounting fees.

 

NOTE 5. LOAN PAYABLE – RELATED PARTY

 

As of March 31, 2024, and June 30, 2023, the balance outstanding under the loan payable - related party was $25,399 and $7,759, respectively.

 

During the nine-month period ended March 31, 2024, one of our directors, who is also our principal shareholder, advanced to us $17,640 by way of a loan to finance our working capital requirements.

 

The loan is unsecured, interest free and due on demand.

 

NOTE 6. PROMISSORY NOTES – RELATED PARTIES

 

As of March 31, 2024, and June 30, 2023, the balance outstanding under promissory notes - related parties was $51,415 and $50,380, respectively. The balances at March 31, 2024 and June 30, 2023 included accrued interest of $1,035 and $270, respectively.

 

We entered into a Promissory Note (“Note 1”) with Legacy Technology Holdings, Inc. for $9,000 due on demand for advances totaling $9,000 made in November 2022. Note 1 incurred no interest unless it defaults after demand and thereafter at 12% per annum. It is unsecured. Our directors, Calvin D. Smiley, Sr. and Redgie Green are also directors of Legacy Technology Holdings, Inc. and Mr. Green is the CEO/President of Legacy Technology Holdings, Inc.

 

Effective February 23, 2023, Note 1 with Legacy Technology Holdings, Inc. was amended such that, commencing January 1, 2023, the Note incurred interest of 6% per year, and was assigned a maturity date of August 31, 2023.

 

Effective March 24, 2023, Note 1 was assigned from Legacy Technology Holdings, Inc. to Perigee Holdings, Inc. whose former directors were Calvin D. Smiley, Sr. and Redgie Green.

 

Note 1 went into default on August 31, 2023. Interest at a default rate of 18% is accruing on Note 1 subsequent to its default.

 

We also entered into a further Promissory Note (“Note 2”) in the amount of $41,110 with Michael A Littman, an affiliate of our principal shareholder, Michael A Littman Atty Defined Benefit Plan in respect of funds he had previously advance to us. Note 2 is due on demand and bears no interest unless demand is made and then the default rate is 12% per annum. It is unsecured.

 

NOTE 7. COMMITMENTS & CONTINGENCIES

 

Legal Proceedings

 

We were not subject to any legal proceedings during the three and nine-month periods ended March 31, 2024 and 2023, and, to the best of our knowledge, no legal proceedings are pending or threatened.

 

 

Contractual Obligations

 

We are not party to any contractual obligations at this time. 

 

NOTE 8. SHAREHOLDERS’ DEFICIT

 

Common Stock

 

As of March 31, 2024, we were authorized to issue 500,000,000 shares of common stock with a par value of $0.0001.

 

No shares of common stock were issued during the three and nine-month periods ended March 31, 2024 and 2023.

 

As of March 31, 2024 and June 30, 2023, 1,697,200 shares of common stock were issued and outstanding.

 

Warrants

 

No warrants were issued or outstanding during the three and nine-month periods ended March 31, 2024 and 2023.

 

Stock Options

 

We currently have no stock option plan.

 

No stock options were issued or outstanding during the three and nine-month periods ended March 31, 2024 and 2023.

 

NOTE 9. SUBSEQUENT EVENTS

 

The Company evaluated subsequent events after March 31, 2024, in accordance with FASB ASC 855 Subsequent Events, through the date of the issuance of these financial statements and has determined there have been no subsequent event for which disclosure is required.

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

Forward-Looking Statements

 

This Form 10-Q contains forward-looking statements that may be affected by matters outside our control that could cause materially different results.

 

Some of the information in this Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933. These statements express, or are based on, our expectations about future events. Forward-looking statements give our current expectations or forecasts of future events. Forward-looking statements generally can be identified by the use of forward-looking terminology, such as, "may", "will", "expect", "intend", "project", "estimate", "anticipate", "believe" or "continue" or the negative thereof or similar terminology. They include statements regarding our:

 

● financial position,

● business plans,

● the future impact of the COVID-19 pandemic,

● budgets,

● amount, nature and timing of capital expenditures,

● cash flow and anticipated liquidity,

● future operations of unknown nature costs,

● acquisition and development of other technology,

● future demand for any products and services acquired,

● operating costs and other expenses.

 

Although we believe the expectations and forecasts reflected in these and other forward-looking statements are reasonable, we can give no assurance they will prove to have been correct. They can be affected by inaccurate assumptions or by known or unknown risks and uncertainties. Factors that could cause actual results to differ materially from expected results include:

 

● general economic conditions,

● the future impact of the COVID-19 pandemic,

● our cost of operations,

● our ability to generate sufficient cash flows to operate,

● availability of capital,

● the strength and financial resources of our competitors,

● our ability to find and retain skilled personnel, and

● the lack of liquidity of our common stock.

 

Any of the factors listed above and other factors contained in this Form 10-Q could cause our actual results to differ materially from the results implied by these or any other forward-looking statements made by us or on our behalf. We cannot assure you that our future results will meet our expectations. When you consider these forward-looking statements, you should keep in mind these risk factors and the other cautionary statements in this Form 10-Q. Our forward-looking statements speak only as of the date made.

 

General Business Plan

 

Our business plan to seek a merger has many uncertainties which pose risks to investors.

 

We intend to seek, investigate and, if such investigation warrants, acquire an interest in business opportunities presented to us by persons or firms which desire to seek the advantages of an issuer who has complied with the Securities Act of 1934 (the “1934 Act”). We will not restrict our search to any specific business, industry or geographical location, and we may participate in business ventures of virtually any nature. This discussion of our proposed business is purposefully general and is not meant to be restrictive of our unlimited discretion to search for and enter into potential business opportunities. We anticipate that we may be able to participate in only one potential business venture because of our lack of financial resources. We may seek a business opportunity with entities which have recently commenced operations, or that desire to utilize the public marketplace in order to raise additional capital in order to expand into new

products or markets, to develop a new product or service, or for other corporate purposes. All of these activities have risk to investors including dilution and management.

 

We expect that the selection of a business opportunity will be complex. Due to general economic conditions, rapid technological advances being made in some industries and shortages of available capital, we believe that there are numerous firms seeking the benefits of an issuer who has complied with the 1934 Act. Such benefits may include facilitating or improving the terms on which additional equity financing may be sought, providing liquidity for incentive stock options or similar benefits to key employees, providing liquidity (subject to restrictions of applicable statutes) for all stockholders and other factors. Potentially, available business opportunities may occur in many different industries and at various stages of development, all of which will make the task of comparative investigation and analysis of such business opportunities extremely difficult and complex. We have, and will continue to have, essentially no assets to provide the owners of business opportunities. However, we will be able to offer owners of acquisition candidates the opportunity to acquire a controlling ownership interest in an issuer who has complied with the 1934 Act without incurring the cost and time required to conduct an initial public offering.

 

The analysis of new business opportunities will be undertaken by, or under the supervision of, our Board of Directors. We intend to concentrate on identifying preliminary prospective business opportunities which may be brought to our attention through present associations of our director, professional advisors or by our stockholders. In analyzing prospective business opportunities, we will consider such matters as (i) available technical, financial and managerial resources; (ii) working capital and other financial requirements; (iii) history of operations, if any, and prospects for the future; (iv) nature of present and expected competition; (v) quality, experience and depth of management services; (vi) potential for further research, development or exploration; (vii) specific risk factors not now foreseeable but that may be anticipated to impact the proposed activities of the company; (viii) potential for growth or expansion; (ix) potential for profit; (x) public recognition and acceptance of products, services or trades; (xi) name identification; and (xii) other factors that we consider relevant. As part of our investigation of the business opportunity, we expect to meet personally with management and key personnel. To the extent possible, we intend to utilize written reports and personal investigation to evaluate the above factors.

 

We will not acquire or merge with any company for which audited financial statements cannot be obtained within a reasonable period of time after closing of the proposed transaction, as required by SEC Rules and Regulations.

 

Acquisition Interest

 

In implementing a structure for a particular business acquisition, we may become a party to a merger, consolidation, reorganization, joint venture, or licensing agreement with another company or entity. We may also acquire stock or assets of an existing business. Upon consummation of the transaction, it is probable that our present management and stockholders will no longer be in control of us. In addition, our directors may, as part of the terms of the acquisition transaction, resign and be replaced by new directors without a vote of our stockholders, or sell their stock in us. Any such sale will only be made in compliance with the securities laws of the United States and any applicable state.

 

It is anticipated that any securities issued in any such reorganization would be issued in reliance upon exemption from registration under application federal and state securities laws. In some circumstances, as a negotiated element of the transaction, we may agree to register all or a part of such securities immediately after the transaction is consummated or at specified times thereafter. If such registration occurs, it will be undertaken by the surviving entity after it has successfully consummated a merger or acquisition and is no longer considered an inactive company.

 

The issuance of substantial additional securities and their potential sale into any trading market which may develop in our securities may have a depressive effect on the value of our securities in the future. There is no assurance that such a trading market will develop.

 

While the actual terms of a transaction cannot be predicted, it is expected that the parties to any business transaction will find it desirable to avoid the creation of a taxable event and thereby structure the business transaction in a so-called “tax-free” reorganization under Sections 368(a)(1) or 351 of the Internal Revenue Code (the “Code”). In order to obtain tax-free treatment under the Code, it may be necessary for the owner of the acquired business to own 80% or more of the voting stock of the surviving entity. In such an event, our stockholders would retain less than 20% of the issued and outstanding shares of the surviving entity. This would result in significant dilution in the equity of our stockholders.

 

With respect to any merger or acquisition, and depending upon, among other things, the target company’s assets and liabilities, our stockholders will in all likelihood hold a substantially lesser percentage ownership interest in us following any merger or acquisition. The percentage ownership may be subject to significant reduction in the event we acquire a target company with assets and expectations of growth. Any merger or acquisition can be expected to have a significant dilutive effect on the percentage of shares held by our stockholders.

 

We will participate in a business opportunity only after the negotiation and execution of appropriate written business agreements. Although the terms of such agreements cannot be predicted, generally we anticipate that such agreements will (i) require specific representations and warranties by all of the parties; (ii) specify certain events of default; (iii) detail the terms of closing and the conditions which must be satisfied by each of the parties prior to and after such closing; (iv) outline the manner of bearing costs, including costs associated with the Company’s attorneys and accountants; (v) set forth remedies on defaults; and (vi) include miscellaneous other terms.

 

As stated above, we will not acquire or merge with any entity which cannot provide independent audited financial statements within a reasonable period of time after closing of the proposed transaction. If such audited financial statements are not available at closing, or within time parameters necessary to ensure our compliance within the requirements of the 1934 Act, or if the audited financial statements provided do not conform to the representations made by that business to be acquired, the definitive closing documents will provide that the proposed transaction will be voidable, at the discretion of our present management. If such a transaction is voided, the definitive closing documents will also contain a provision providing for reimbursement for our costs associated with the proposed transaction.

 

Competition

 

We believe we are an insignificant participant among the firms which engage in the acquisition of business opportunities. There are many established venture capital and financial concerns that have significantly greater financial and personnel resources and technical expertise than we have. In view of our limited financial resources and limited management availability, we will continue to be at a significant competitive disadvantage compared to our competitors.

 

Investment Company Act 1940

 

Although we will be subject to regulation under the Securities Act of 1933, as amended, and the 1934 Act, we believe we will not be subject to regulation under the Investment Company Act of 1940 (the “1940 Act”) insofar as we will not be engaged in the business of investing or trading in securities. In the event we engage in business combinations that result in us holding passive investment interests in a number of entities, we could be subject to regulation under the 1940 Act. In such an event, we would be required to register as an investment company and incur significant registration and compliance costs. We have obtained no formal determination from the SEC as to our status under the 1940 Act and, consequently, any violation of the 1940 Act would subject us to material adverse consequences. We believe that, currently, we are exempt under Regulation 3a-2 of the 1940 Act.

 

Intellectual Property

 

We have not and do not own any intellectual property.

 

Employees

 

We presently have no full-time executive, operational or clerical staff.

 

We operate with three directors and two officers who provide their services to us on a part time basis:

 

Calvin D. Smiley, Sr. is our Chief Executive Officer, President, Acting Chief Financial Officer and a director; Michael A. Littman is our secretary and director; and Redgie Green is a director.

 

 

 

 

 

Revenue

 

We have not recorded any revenues during the three and nine-month periods ended March 31, 2024 and 2023.

 

Factors Effecting Future Performance

 

Our goal is to obtain debt and/or equity finance to meet our ongoing operating expenses and attempt to merge with another entity with experienced management and opportunities for growth in return for shares of our common stock to create value for our shareholders.

 

Although there is no assurance that this series of events will be successfully completed, we believe we can successfully complete an acquisition or merger which will enable us to continue as a going concern.

 

Any acquisition or merger will most likely be dilutive to our existing stockholders.

 

RESULTS OF OPERATIONS

 

Our plan of operations is to raise debt and/or equity to meet our ongoing operating expenses and seek to merge with another entity with experienced management and opportunities for growth in return for shares of our common stock to create value for our shareholders. There can be no assurance that we will successfully complete this series of transactions. In particular, there is no assurance that any stockholder will realize any return on their shares after such a transaction. Any merger or acquisition completed by us can be expected to have a significant dilutive effect on the percentage of shares held by our current stockholders.

 

THREE-MONTH PERIOD ENDED MARCH 31, 2024 COMPARED TO THE THREE-MONTH PERIOD ENDED MARCH 31, 2023

 

Revenue

 

We recognized no revenue during the three-month period ended March 31, 2024 or 2023 as we had no revenue generating activities during this period.

 

General and Administrative Expenses

 

During the three-month period ended March 31, 2024, we incurred general and administrative expenses of $5,462, comprising accounting fees of $3,100, share transfer agent fees of $2,144, EDGAR filing fees of $188 and other fees of $30.

 

By comparison, during the three-month period ended March 31, 2023, we incurred general and administrative expenses of $10,479, comprising share transfer agent fees of $4,325, accounting fees of $3,950, OTC market fees of $1,375, state filing fees of $659 and other expenses of $170.

 

Operating loss

 

During the three-month period ended March 31, 2024 and 2023, we incurred operating losses of $5,462 and $10,479, respectively, due to the factors described above.

 

Other income (expense)

 

During the three-month periods ended March 31, 2024, we incurred interest expense – related party of $405.

 

During the three-month period ended March 31, 2023, we recognized no other income (expense).

 

 

 

 

 

 

Loss before Income Tax

 

During the three-month periods ended March 31, 2024 and 2023, we recognized losses before income taxes of $5,867 and $10,479, respectively, due to the factors described above.

 

Provision for Income Tax

 

No provision for income taxes was recorded during the three-month periods ended March 31, 2024 and 2023 as we incurred taxable losses in both periods.

 

Net Loss

 

During the three-month periods ended March 31, 2024 and 2023, we recognized net losses of $5,867 and $10,479, respectively, due to the factors described above.

 

NINE-MONTH PERIOD ENDED MARCH 31, 2024 COMPARED TO THE NINE-MONTH PERIOD ENDED MARCH 31, 2023

 

Revenue

 

We recognized no revenue during the nine-month period ended March 31, 2024 or 2023 as we had no revenue generating activities during this period.

 

General and Administrative Expenses

 

During the nine-month period ended March 31, 2024, we incurred general and administrative expenses of $31,104, comprising accounting fees of $13,312, auditing fees of $10,000, share transfer agent fees of $6,471, EDGAR filing fees of $1,128, office expenses of $103 and other fees of $90.

 

By comparison, during the nine-month period ended March 31, 2023, we incurred general and administrative expenses of $27,537, comprising accounting fees of $10,950, share transfer agent fees of $5,826, OTC market fees of $4,583, auditing fees of $3,750, EDGAR filing fees of $1,500, state filings fees of $758 and other expenses of $170.

 

Operating loss

 

During the nine-month period ended March 31, 2024 and 2023, we incurred operating losses of $31,104 and $27,537, respectively, due to the factors described above.

 

Other income (expense)

 

During the nine-month period ended March 31, 2024 we incurred $1,035 interest expense on one of our related party promissory notes.

 

We incurred no other expense during the nine-month period ended March 31, 2023.

 

Loss before Income Tax

 

During the nine-month periods ended March 31, 2024 and 2023, we recognized losses before income taxes of $32,139 and $27,537, respectively, due to the factors described above.

 

Provision for Income Tax

 

No provision for income taxes was recorded during the nine-month periods ended March 31, 2024 and 2023 as we incurred taxable losses in both periods.

 

 

 

Net Loss

 

During the nine-month periods ended March 31, 2024 and 2023, we recognized net losses of $32,139 and $27,537, respectively, due to the factors described above.

 

CASH FLOW

 

As of March 31, 2024, we had cash of $132, no revenue generating activities or other source of income and we had outstanding liabilities of $123,997 and a shareholders’ deficit of $123,865.

 

By comparison, as of June 30, 2023, we have cash of $325, no revenue generating activities or other source of income and we had outstanding liabilities of $92,051 and a shareholders’ deficit of $91,726.

 

Consequently, we are now dependent on raising additional equity and/or debt to meet our ongoing operating expenses. There is no assurance that we will be able to raise the necessary equity and/or debt that we will need to fund our ongoing operating expenses.

 

We will be reliant, potentially, on advances from our principal shareholders or our directors and officers. There can be no guarantee that we will be able to obtain sufficient funding from these sources.

 

Our principal shareholder has indicated his intention to provide such funds as may be required for the Company to become, and remain, a fully reporting public company while seeking to create value for shareholders by merging with another entity with experienced management and opportunities for growth in return for shares of its common stock. Such intentions do not represent a binding commitment by the principal shareholder and there is no guarantee that our two principal shareholders will be able to provide the funding necessary to achieve this objective.

 

We currently believe that our principal shareholder will be able to provide us with the funding necessary to effect our business plan to merge with another entity. However, while our principal shareholder has indicated his intention to provide us with sufficient funding to achieve this objective, there is no guarantee that he will be able to provide the funding necessary to enable us to merge with another entity.

 

If we are unable to obtain the necessary funding from our principal shareholder, we anticipate facing major challenges in raising the necessary funding to effect our business plan to merge with another entity. Raising debt or equity funding for small publicly quoted, penny stock, shell companies is always extremely challenging.

 

Future losses are likely to occur as, until we are able to merge with another entity with experienced management and opportunities for growth in return for shares of our common stock to create value for our shareholders, we have no sources of income to meet our operating expenses. As a result of these, among other factors, we received from our registered independent public accountants in their report for the financial statements for the years ended June 30, 2023 and 2022, an explanatory paragraph stating that there is substantial doubt about our ability to continue as a going concern.

 

The following is a summary of the Company’s cash flows provided by (used in) operating, investing, and financing activities for the nine-month periods ended March 31, 2024 and 2023:

 

		Nine- months ended March 31, 2024				Nine- months ended March 31, 2023
Net Cash Used in Operating Activities		$	(18,868	)		$	(15,665	)
Net Cash Used in Investing Activities			—				—
Net Cash Provided by Financing Activities			18,675				16,020
Net Change in Cash		$	(193	)		$	355
Cash, beginning of period			325				—
Net Change in Cash		$	(132	)		$	355

 

 

  

Operating Activities

 

During the nine-month period ended March 31,2024, we incurred a net loss of $32,139 which after adjustment for a $13,271 increase in accounts payable and accruals resulted in net cash of $18,868 being used in operating activities.

 

By comparison, during the nine-month period ended March 31, 2023, we recognized a net loss $27,537 which was reduced for cash flow purposes by a $4,583 decrease in prepaid expenses and a $7,289 increase in accounts payable and accruals resulting in net cash of $15,665 being used in operating activities.

 

Investing Activities

 

During the nine-month periods ended March 31, 2024 and 2023, we had no investing activities.

 

Financing Activities

  

During the nine-month period ended March 31, 2024, received $17,640 by way of loan from a related party and accrued $1,035 interest on one of our promissory notes related party resulting in net cash of $18,675 being provided by financing activities.

 

By comparison, during the nine-month period ended March 31, 2023, we received net cash flows of $16,020 from financing activities: $9,020 by way of loan from a related party and $7,000 by way of a promissory note from another related party.

 

We are dependent upon the receipt of capital investment or other financing to fund our ongoing operations and to execute our business plan to merge with another entity with experienced management and opportunities for growth in return for shares of our common stock to create value for our shareholders. In addition, we are dependent upon our controlling shareholder to provide continued funding and capital resources. If continued funding and capital resources are unavailable at reasonable terms, we may not be able to implement our plan of operations.

 

CRITICAL ACCOUNTING POLICIES

 

All companies are required to include a discussion of critical accounting policies and estimates used in the preparation of their financial statements. On an on-going basis, we evaluate our critical accounting policies and estimates. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form our basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

 

Our significant accounting policies are described in Note 3 of our Condensed Unaudited Financial Statements above. These policies were selected because they represent the more significant accounting policies and methods that are broadly applied in the preparation of our financial statements.

 

Inflation

 

To date inflation has not been a major factor in our proposed business plan. However, there are significant inflationary pressures in the larger economy. The impact of inflation is being reflected in higher wages, increased pricing of equipment and products and generally higher prices across all sectors of the economy. We plan on carefully evaluating the impact of inflation and price increase pressures on our proposed business plan.

 

Off -Balance Sheet Arrangements

 

Per SEC regulations, we are required to disclose our off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, such as changes in financial condition, revenues, expenses, results of operations, liquidity, capital expenditures, or capital resources that are material to investors. As of March 31, 2024 and June 30, 2023, we had no off-balance sheet arrangements.

 

 

Share-based Compensation

 

The cost of equity instruments issued to non-employees in return for goods and services is measured by the fair value of the equity instruments issued in accordance with ASC 718, “Compensation - Stock Compensation.” The measurement date for non-employees is the grant date of the stock-based compensation. The cost of employee services received in exchange for equity instruments is based on the grant date fair value of the equity instruments issued.

 

Recently Issued Accounting Pronouncements

 

We have reviewed all the recently issued, but not yet effective, accounting pronouncements and do not believe any of these pronouncements will have a material impact on our financial statements.

 

Contractual Obligations

 

The only contractual obligations are in respect of loan payable – related party and the promissory notes payable – related parties described in the condensed unaudited financial statements above.

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

 

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, the Company is not required to provide information required by this Item.

 

Item 4. Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures

 

Our management conducted an evaluation, with the participation of our Chief Executive Officer, who is our principal executive officer, who is also our acting principal financial and accounting officer, of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this Form 10-Q. Based on that evaluation, we concluded that because of the material weakness and significant deficiencies in our internal control over financial reporting described below, our disclosure controls and procedures were not effective as of March 31, 2024.

 

Management’s Annual Report on Internal Control over Financial Reporting

 

Management is responsible for the preparation of our financial statements and related information. Management uses its best judgment to ensure that the financial statements present accurately, in material respects, our financial position and results of operations in fairness and conformity with generally accepted accounting principles.

 

Management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in the Exchange Act. These internal controls are designed to provide reasonable assurance that the reported financial information is presented fairly, that disclosures are adequate, and that the assumptions and opinions in the preparation of financial statements are reasonable. There are inherent limitations in the effectiveness of any system of internal controls, including the possibility of human error and overriding of controls. Consequently, an ineffective internal control system can only provide reasonable, not absolute, assurance with respect to reporting financial information.

 

Our internal control over financial reporting includes policies and procedures that: (i) pertain to maintaining records that, in reasonable detail, accurately and fairly reflect our transactions; (ii) provide reasonable assurance that transactions are recorded as necessary for preparation of our financial statements in accordance with generally accepted accounting principles and that the receipts and expenditures of company assets are made in accordance with our management’s and directors’ authorization; and (iii) provide reasonable assurance regarding the prevention or timely detection of unauthorized acquisition, use, or disposition of assets that could have a material effect on our financial statements.

 

We conducted an evaluation of the effectiveness of our internal control over financial reporting, based on the framework in “Internal Control Integrated Framework” issued by the Committee of Sponsoring Organizations of the Treadway

Commission (“COSO”) and published in 2013, and subsequent guidance prepared by COSO specifically for smaller public companies. Based on that evaluation, management concluded that our internal control over financial reporting was not effective as of March 31, 2024 for the reasons discussed below.

 

A significant deficiency is a deficiency, or combination of deficiencies in internal control over financial reporting, that adversely affects the entity’s ability to initiate, authorize, record, process, or report financial data reliably in accordance with generally accepted accounting principles such that there is more than a remote likelihood that a misstatement of the entity’s financial statements that is more than inconsequential will not be prevented or detected by the entity’s internal control. A material weakness is a deficiency or a combination of deficiencies in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the annual or interim consolidated financial statements will not be prevented or detected on a timely basis. Management identified the following material weakness and significant deficiencies in its assessment of the effectiveness of internal control over financial reporting as of March 31, 2024:

 

● The Company did not maintain effective controls over certain aspects of the financial reporting process because we lacked personnel with accounting expertise and an adequate supervisory review structure that is commensurate with our financial reporting requirements.

● Material Weakness – Inadequate segregation of duties.

 

There are no assurances that the material weaknesses and significant deficiencies in our disclosure controls and procedures and internal control over financial reporting will not result in errors in our financial statements, which could lead to a restatement of those financial statements. Our management does not expect that our disclosure controls and procedures or our internal controls will prevent all error and all fraud. A control system, no matter how well conceived and maintained, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must account for resource constraints. In addition, the benefits of controls must be considered relative to their costs. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, can and will be detected.

 

This Form 10-Q does not include an attestation report from our registered public accounting firm regarding internal control over financial reporting. The management’s report was not subject to attestation by the Company’s registered public accounting firm pursuant to rules of the Commission that permit us to provide only management’s report in this Form 10-Q.

 

Changes in Internal Controls over Financial Reporting

 

There have been no changes in our internal control over financial reporting during the three months period ended March 31, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

PART II

 

OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

There are presently no material pending legal proceedings to which the Company, any executive officer, any owner of record or beneficially of more than five percent of any class of voting securities is a party or as to which any of its property is subject, and no such proceedings are known to the Company to be threatened or contemplated against it.

 

Item 1A. Risk Factors.

 

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, the Company is not required to provide information required by this Item.

 

Item 2. Unregistered Sale of Equity Securities and Use of Proceeds.

 

None.

 

Item 3. Defaults Upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

Not applicable to our Company.

 

Item 5. Other Information.

 

None.

 

Item 6. Exhibits.

 

Exhibits. The following is a complete list of exhibits filed as part of this Form 10-Q. Exhibit numbers correspond to the numbers in the Exhibit Table of Item 601 of Regulation S-K.

 

31.1	Certification of Chief Executive Officer and Acting Chief Financial Officer Pursuant to Rule 13a–14(a) or 15d-14(a) of the Securities Exchange Act of 1934
32.1	Certification of Chief Executive Officer and Acting Chief Financial Officer under Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS	XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH	Inline XBRL Taxonomy Extension Schema Document
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document
104	Cover Page Interactive Data File (formatted as an Inline XBRL document and included in Exhibit 101)

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

May 20, 2024	VECTOR 21 HOLDINGS, INC.
	/s/ Calvin D. Smiley, Sr.
	Calvin D. Smiley, Sr.,
	Chief Executive Officer and Director
	(Principal Executive Officer)
	/s/ Calvin D. Smiley, Sr.
	Calvin D. Smiley, Sr., Acting Chief Financial Officer and Director (Principal Accounting Officer)

 

 

 

EXHIBIT 31.1

 

CERTIFICATION OF PERIODIC REPORT

 

I, Calvin D. Smiley, Sr., certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Vector 21 Holdings, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f)) for the registrant and have:

 

a. Designed such disclosure controls and procedures or caused such disclosure controls and procedures to be designed under our supervision to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared.

 

b. Designed such internal control over financial reporting or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.

 

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s 4th quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

 

5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b. Any fraud, whether or not material, which involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 20, 2024

 

/s/ Calvin D. Smiley, Sr.

______________________________________________

Calvin D. Smiley, Sr.

Chief Executive Officer and Acting Chief Financial Officer

(Principal Executive Officer and Principal Accounting Officer)

 

EXHIBIT 32.1

 

CERTIFICATION OF DISCLOSURE PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

 

In connection with the Quarterly Report of Vector 21 Holdings, Inc. (the “Company”) on Form 10-Q for the quarter ending March 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Calvin D. Smiley, Sr., Chief Executive Officer and Principal Executive Officer and Acting Chief Financial Officer and Principal Accounting Officer of the Company, certify, pursuant to 18 USC section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge and belief:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: May 20, 2024

 

 

/s/ Calvin D. Smiley, Sr.

___________________________________________

Calvin D. Smiley, Sr.,

Chief Executive Officer & Principal Executive Officer

Acting Chief Financial Officer & Principal Accounting Officer

 

This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

 

v3.24.1.1.u2

Cover - shares	9 Months Ended
	Mar. 31, 2024	May 15, 2024
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes
Amendment Flag	false
Document Period End Date	Mar. 31, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Entity Information [Line Items]
Entity Registrant Name	VECTOR 21 HOLDINGS, INC.
Entity Central Index Key	0001916879
Entity File Number	000-56418
Entity Tax Identification Number	88-1065560
Entity Incorporation, State or Country Code	DE
Current Fiscal Year End Date	--06-30
Entity Current Reporting Status	Yes
Entity Shell Company	true
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Contact Personnel [Line Items]
Entity Address, Address Line One	12136 West Bayaud Avenue
Entity Address, Address Line Two	Suite 300
Entity Address, City or Town	Lakewood
Entity Address, State or Province	CO
Entity Address, Postal Zip Code	80228
Entity Phone Fax Numbers [Line Items]
City Area Code	303
Local Phone Number	422-8127
Entity Listings [Line Items]
Entity Common Stock, Shares Outstanding		1,697,200

v3.24.1.1.u2

Condensed Unaudited Balance Sheets - USD ($)	Mar. 31, 2024	Jun. 30, 2023
Current Assets
Cash and cash equivalents	$ 132	$ 325
Total Current Assets	132	325
Total Assets	132	325
Current Liabilities
Accounts payable and accruals	47,183	33,912
Total Current Liabilities	123,997	92,051
Total Liabilities	123,997	92,051
Commitments and Contingencies (Note 7)
Shareholders' Deficit
Common stock, $0.0001 par value, 500,000,000 shares authorized, 1,697,200 shares issued and outstanding	170	170
Additional paid in capital	17,673,072	17,673,072
Accumulated Deficit	(17,797,107)	(17,764,968)
Total Shareholders' Deficit	(123,865)	(91,726)
Total Liabilities and Shareholders' Deficit	132	325
Related Party
Current Liabilities
Loan payable - related party	25,399	7,759
Promissory notes - related parties	$ 51,415	$ 50,380

v3.24.1.1.u2

Condensed Unaudited Balance Sheets (Parentheticals) - $ / shares	Mar. 31, 2024	Jun. 30, 2023
Statement of Financial Position [Abstract]
Common stock par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	500,000,000	500,000,000
Common stock, shares issued	1,697,200	1,697,200
Common stock, shares outstanding	1,697,200	1,697,200

v3.24.1.1.u2

Condensed Unaudited Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
REVENUE
OPERATING EXPENSES:
General and administrative expenses	5,462	10,479	31,104	27,537
TOTAL OPERATING EXPENSES	5,462	10,479	31,104	27,537
OPERATING LOSS	(5,462)	(10,479)	(31,104)	(27,537)
OTHER EXPENSE
Interest expense – related party	(405)		(1,035)
LOSS BEFORE TAXES	(5,867)	(10,479)	(32,139)	(27,537)
TAXES
NET LOSS	$ (5,867)	$ (10,479)	$ (32,139)	$ (27,537)
Weighted average shares outstanding- basic (in Shares)	1,697,200	1,697,200	1,697,200	1,697,200
Net loss per share – basic (in Dollars per share)	$ (0.01)	$ (0.01)	$ (0.01)	$ (0.01)

v3.24.1.1.u2

Condensed Unaudited Statements of Operations (Parentheticals) - $ / shares	3 Months Ended		9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Weighted average shares outstanding - diluted	1,697,200	1,697,200	1,697,200	1,697,200
Net loss per share – diluted	$ (0.01)	$ (0.01)	$ (0.01)	$ (0.01)

v3.24.1.1.u2

Condensed Unaudited Statements of Changes in Shareholders' Deficit - USD ($)	Common Shares	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Jun. 30, 2022	$ 170	$ 17,673,072	$ (17,730,699)	$ (57,457)
Balance (in Shares) at Jun. 30, 2022	1,697,200
Net loss for the period			(27,537)	(27,537)
Balance at Mar. 31, 2023	$ 170	17,673,072	(17,758,236)	(84,994)
Balance (in Shares) at Mar. 31, 2023	1,697,200
Balance at Dec. 31, 2022	$ 170	17,673,072	(17,747,757)	(74,515)
Balance (in Shares) at Dec. 31, 2022	1,697,200
Net loss for the period			(10,479)	(10,479)
Balance at Mar. 31, 2023	$ 170	17,673,072	(17,758,236)	(84,994)
Balance (in Shares) at Mar. 31, 2023	1,697,200
Balance at Jun. 30, 2023	$ 170	17,673,072	(17,764,968)	$ (91,726)
Balance (in Shares) at Jun. 30, 2023	1,697,200			1,697,200
Net loss for the period			(32,139)	$ (32,139)
Balance at Mar. 31, 2024	$ 170	17,673,072	(17,797,107)	$ (123,865)
Balance (in Shares) at Mar. 31, 2024	1,697,200			1,697,200
Balance at Dec. 31, 2023	$ 170	17,673,072	(17,791,240)	$ (117,998)
Balance (in Shares) at Dec. 31, 2023	1,697,200
Net loss for the period			(5,867)	(5,867)
Balance at Mar. 31, 2024	$ 170	$ 17,673,072	$ (17,797,107)	$ (123,865)
Balance (in Shares) at Mar. 31, 2024	1,697,200			1,697,200

v3.24.1.1.u2

Condensed Unaudited Statements of Cash Flows - USD ($)	9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash Flows from Operating Activities:
Net Loss	$ (32,139)	$ (27,537)
Changes in working capital items:
Prepaid Expenses		4,583
Accounts Payable & Accruals	13,271	7,289
Net Cash Flows Used in Operating Activities	(18,868)	(15,665)
Cash Flows from Financing Activities
Loan Payable- Related Party	17,640	9,020
Advances Under Promissory Notes – Related Parties	1,035	7,000
Net Cash Flows from Financing Activities	18,675	16,020
Net increase (decrease) in Cash:	(193)	355
Cash, beginning of period:	325
Cash, end of period:	132	355
Supplemental Disclosures of Cash Flow Information:
Cash paid for interest
Cash paid for income tax
Non-Cash Investing and Financing Activities
Conversion of loan payable - related party to Promissory Note Payable - Related Party		$ 41,110

v3.24.1.1.u2

Nature of Operations	9 Months Ended
	Mar. 31, 2024
Nature of Operations [Abstract]
NATURE OF OPERATIONS	NOTE 1. NATURE OF OPERATIONS   Nature of Business   Vector 21 Holdings, Inc., a Delaware corporation, (“Vector 21”, “the Company”, “We", "Us" or “Our’) is a publicly quoted shell company seeking to merge with an entity with experienced management and opportunities for growth in return for shares of our common stock to create values for our shareholders. No potential merger candidate has been identified at this time.   History   Vector 21 was incorporated in Delaware on March 5, 2021.   Effective April 28, 2021, following a corporate reorganization as described below (‘the Holding Company Reorganization” or ‘the reverse recapitalization”), Vector 21 became the reorganized successor to Momentum Biofuels, Inc. (“Predecessor Company”), a publicly quoted holding company that ceased trading in 2012.   Reorganization into a Holding Company Structure for Vector 21 Holdings, Inc., reorganization successor to Momentum Biofuels, Inc.   Effective March 10, 2021, Momentum Biofuels, Inc. (“Momentum Biofuels Colorado”), a Colorado corporation, redomiciled to Delaware by merging with its wholly owned subsidiary, Momentum Biofuels, Inc., a Delaware corporation.   Momentum Biofuels Colorado ceased to exist as an independent legal entity following its merger with Momentum Biofuels Delaware.   Pursuant to the Delaware Holding Company formation statute, DGCL Section 251(g), Momentum Biofuels Delaware entered into an Agreement and Plan of Merger and Reorganization into a Holding Company with Vector 21 Holdings, Inc. (“Vector 21”) and MBF Ops, Inc. (“MBF Ops.”), both wholly owned subsidiaries of Momentum Biofuels Delaware, effective April 28, 2021.   The Agreement and Plan of Merger and Reorganization into a Holding Company provided for the merger of Momentum Biofuels Delaware with, and into MBF Ops., with MBF Ops. being the surviving corporation in the merger, as a subsidiary to Vector 21.   Momentum Biofuels Delaware ceased to exist as an independent legal entity following its merger with MBF Ops.   The shareholders of Momentum Biofuels Delaware were converted, by the holding company reorganization, under the Agreement, to shareholders of Vector 21 on a one for one basis pursuant to the Agreement and the Delaware Statute Sec. 251(g).   MBF Ops., the surviving company of the merger with Momentum Biofuels Delaware, became a wholly owned subsidiary of Vector 21, the holding company.   Vector 21 became the parent holding company resulting under the Agreement, pursuant to Delaware General Corporation Law section 251(g), with its wholly owned subsidiary company, MBF Ops, the surviving company of the merger with Momentum Biofuels Delaware. As a result of the Holding Company Reorganization, shareholders in the publicly quoted Momentum Biofuels Delaware, formerly the shareholders of Momentum Biofuels Colorado as of the date of the reorganization, became shareholders in the publicly quoted Vector 21.   MBF Ops, being the direct successor by the merger with Momentum Biofuels Delaware, became a subsidiary company of Vector 21.   Disposal of MBF Ops.   Effective June 28, 2021, Vector 21 disposed of 100% of the issued share capital of its sole subsidiary company, MBF Ops., to an unrelated third party. We made a $1,000 payment in cash and promised to issue 50,000 post-split shares of our common stock to the company (MBF) as capital for the subsidiary company which had no ongoing business or assets and outstanding liabilities of $1,130,842. These shares of common stock have been issued to the Purchaser as of the date of these financial statements. The Holding Company Reorganization has been accounted for so as to reflect the fact that both Momentum Biofuels Delaware and Vector 21 were under common control at the date of the Holding Company Reorganization.   Reverse and Forward Stock Splits   Effective May 13, 2021, we completed:     - a reverse stock split of our outstanding common stock, $0.0001 par value, on a one (1) post-split share for eight thousand (8,000) pre-split shares basis, and subsequently     - a forward stock split of our post reverse split outstanding common stock, $0.0001 par value, on a one hundred (100) post-split shares for one (1) pre-split share basis.   As a result of the 8,000: 1 reverse stock split described above, the number of issued and outstanding shares of the Company’s common stock was reduced from 123,224,444 to 15,403. No fractional shares were issued in connection with the reverse stock split. Instead, a holder of record of common stock who would otherwise be entitled to a fraction of a share was, in lieu thereof, entitled to receive a whole share of common stock. Consequently 1,069 additional shares were issued in respect of fractional shares and therefore a total of 16,472 shares of common stock were issued and outstanding after the reverse split.   As a result of 1:100 forward stock split described above, the number of issued and outstanding shares of the Company’s common stock increased from 16,472 to 1,647,200.   A total of 1,697,200 shares of common stock are currently outstanding on the date of the filing.   Impact of the Ukrainian and Israeli Conflicts   We believe that the conflicts involving Ukraine and Israel do not have any direct impact on our operations, financial condition, or financial reporting.  We believe the conflicts will have only a general impact on our operations in the same manner as it is having a general impact on all businesses that have their operations limited to North America resulting from international sanction and embargo regulations, possible shortages of goods and goods incorporating parts that may be supplied from countries involved in the conflicts, supply chain challenges, and the international and US domestic inflation resulting from the conflict and government spending in relation to the conflicts. As we are a shell company, we do not believe we will be targeted for cyber-attacks related to the conflicts. We have no operations in the countries directly involved in the conflict or are specifically impacted by any of the sanctions and embargoes, as we principally operate solely in the United States. We do not believe that the conflicts will have any impact on our internal control over financial reporting.  Other than general securities market trends, we do not have reason to believe that investors will evaluate the company as having special risks or exposures related to the conflicts. Inflation   We anticipate that our business and financial position will be impacted by the current inflationary environment. To the extent that we use borrowed funds, we believe costs will increase for us. Access to capital will be impacted by increased interest rates and may affect our ability to obtain capital. Inflation will also have an impact on the cost of supplies of goods and services that we use with the consequence of an adverse impact on our operating costs.

v3.24.1.1.u2

Going Concern	9 Months Ended
	Mar. 31, 2024
Going Concern [Abstract]
GOING CONCERN	NOTE 2. GOING CONCERN   Our financial statements are prepared using accounting principles generally accepted in the United States of America (“GAAP”) applicable to a going concern, which contemplate the realization of assets and the liquidation of liabilities in the normal course of business. We have no ongoing business or income and for the nine-months period ended March 31, 2024 we incurred a loss of $32,139 and had an accumulated deficit of $17,797,107 as of March 31, 2024. These conditions raise substantial doubt about our ability to continue as a going concern. The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the outcome of these uncertainties. Our ability to continue as a going concern is dependent upon our ability to raise additional debt or equity funding to meet our ongoing operating expenses and ultimately in merging with another entity with experienced management and profitable operations. No assurances can be given that we will be successful in achieving these objectives.

v3.24.1.1.u2

Summary of Significant Accounting Policies	9 Months Ended
	Mar. 31, 2024
Summary of Significant Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES   Basis of Presentation   This summary of significant accounting policies is presented to assist in the understanding of financial statements. These policies conform to GAAP and have been consistently applied. The Company has selected June 30 as its financial year end.   Interim Financial Statements   The accompanying unaudited interim condensed financial statements have been prepared in accordance with GAAP for interim financial information in accordance with Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The accompanying condensed financial statements have been prepared by the Company without audit. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations, changes in shareholders’ deficit and cash flows as of March 31, 2024 and for the related periods presented, have been included. The results for the three- and nine-months period ended March 31, 2024 are not necessarily indicative of the results of operations for the full year. These financial statements and related footnotes should be read in conjunction with the financial statements and footnotes thereto for the years ended June 30, 2023 and 2022 included in our Form 10-12G/A filed on October 30, 2023.   Use of Estimates   The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.   Cash and Cash Equivalents:   We maintain cash balances in a non-interest-bearing account that currently does not exceed federally insured limits. For the purpose of the statements of cash flows, all highly liquid investments with a maturity of three months or less are considered to be cash equivalents. As of March 31, 2024, and June 30, 2023, our cash balances were $132 and $325 respectively. Fair Value Measurements:   ASC Topic 820, Fair Value Measurements and Disclosures ("ASC 820"), provides a comprehensive framework for measuring fair value and expands disclosures which are required about fair value measurements. Specifically, ASC 820 sets forth a definition of fair value and establishes a hierarchy prioritizing the inputs to valuation techniques, giving the highest priority to quoted prices in active markets for identical assets and liabilities and the lowest priority to unobservable value inputs. ASC 820 defines the hierarchy as follows:   Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reported date. The types of assets and liabilities included in Level 1 are highly liquid and actively traded instruments with quoted prices, such as equities listed on the New York Stock Exchange.   Level 2 – Pricing inputs are other than quoted prices in active markets but are either directly or indirectly observable as of the reported date. The types of assets and liabilities in Level 2 are typically either comparable to actively traded securities or contracts or priced with models using highly observable inputs.   Level 3 – Significant inputs to pricing that are unobservable as of the reporting date. The types of assets and liabilities included in Level 3 are those with inputs requiring significant management judgment or estimation, such as complex and subjective models and forecasts used to determine the fair value of financial transmission rights.   Our financial instruments consist of our prepaid expenses, accounts payable and accruals, loan payable- related party and promissory note- related party. The carrying amount of our prepaid expenses, accounts payable and accruals, loan payable- related party and promissory note- related party approximates their fair values because of the short-term maturities of these instruments.   Related Party Transactions:   A related party is generally defined as (i) any person that holds 10% or more of our membership interests including such person's immediate families, (ii) our management, (iii) someone that directly or indirectly controls, is controlled by or is under common control with us, (iv) any person who is or was (since the beginning of the last fiscal year for which the Company has filed an Annual Report on Form 10-K and proxy statement, even if such person does not presently serve in that role) an executive officer, director or nominee for director of the Company, or (v) anyone who can significantly influence our financial and operating decisions. A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties. See Notes 5 and 6 below for details of related party transactions in the period presented.   Leases:   We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) as assets, operating lease non-current liabilities, and operating lease current liabilities in our balance sheet. Finance leases are property and equipment, other current liabilities, and other non-current liabilities in the balance sheet.   ROU assets represent the right to use an asset for the lease term and lease liability represent the obligation to make lease payment arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over lease term. As most of the leases doesn’t provide an implicit rate. We generally use the incremental borrowing rate on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. The operating ROU asset also includes any lease payments made and excludes lease incentives. Lease expense for lease payment is recognized on a straight-line basis over lease term.   The Company was not party to any lease transaction during the three and nine-month periods ended March 31, 2024 and 2023. Income Taxes:   The provision for income taxes is computed using the asset and liability method, under which deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating losses and tax credit carryforwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates that apply to taxable income in effect for the years in which those tax assets are expected to be realized or settled. We record a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.   Uncertain Tax Positions:   We evaluate tax positions in a two-step process. We first determine whether it is more likely than not that a tax position will be sustained upon examination, based on the technical merits of the position. If a tax position meets the more-likely-than-not recognition threshold, it is then measured to determine the amount of benefit to recognize in the financial statements. The tax position is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement. We classify gross interest and penalties and unrecognized tax benefits that are not expected to result in payment or receipt of cash within one year as long-term liabilities in the financial statements.   Revenue Recognition:   Revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:   Step 1: Identify the contract(s) with customers. Step 2: Identify the performance obligations in the contract. Step 3: Determine the transaction price. Step 4: Allocate the transaction price to performance obligations. Step 5: Recognize revenue when the entity satisfies a performance obligation.   As the Company had no business operations during the three and nine-month periods ended March 31, 2024 and 2023, we have not identified specific planned revenue streams.   During the three and nine-month periods ended March 31, 2024 and 2023, we did not recognize any revenue.   Advertising Costs:   We expense advertising costs when advertisements occur. No advertising costs were incurred during the three and nine-month periods ended March 31, 2024 and 2023.   Stock-Based Compensation:   The cost of equity instruments issued to employees and non-employees in return for goods and services is measured by the grant date fair value of the equity instruments issued in accordance with ASC 718, Compensation – Stock Compensation. The related expense is recognized as services are rendered or vesting periods elapse.   Net Loss per Share Calculation:   Basic earnings (loss) per common share ("EPS") is computed by dividing net income (loss) available to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings (loss) per share is computed by dividing net income (loss) by the weighted average shares outstanding, assuming all dilutive potential common shares were issued. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive. No potentially dilutive debt or equity instruments were issued or outstanding during the three and nine-month periods ended March 31, 2024 and 2023.   Recently Accounting Pronouncements:   We have reviewed all the recently issued, but not yet effective, accounting pronouncements and do not believe any of these pronouncements will have a material impact on our financial statements.

v3.24.1.1.u2

Accounts Payable and Accruals	9 Months Ended
	Mar. 31, 2024
Accounts Payable and Accruals [Abstract]
ACCOUNTS PAYABLE AND ACCRUALS	NOTE 4. ACCOUNTS PAYABLE AND ACCRUALS   As of March 31, 2024, and June 30, 2023, the balance of accounts payable and accrued expenses was $47,183 and $33,912, respectively.   As of March 31, 2024, $35,733 of the balance was due to our share transfer agent, $6,450 related to accounting fees and $5,000 related to audit fees. As of June 30, 2023, $29,262 of the balance was due to our share transfer agent and $4,650 related to accounting fees.

v3.24.1.1.u2

Loan Payable – Related Party	9 Months Ended
	Mar. 31, 2024
Loan Payable – Related Party [Abstract]
LOAN PAYABLE – RELATED PARTY	NOTE 5. LOAN PAYABLE – RELATED PARTY   As of March 31, 2024, and June 30, 2023, the balance outstanding under the loan payable - related party was $25,399 and $7,759, respectively.   During the nine-month period ended March 31, 2024, one of our directors, who is also our principal shareholder, advanced to us $17,640 by way of a loan to finance our working capital requirements.   The loan is unsecured, interest free and due on demand.

v3.24.1.1.u2

Promissory Notes – Related Parties	9 Months Ended
	Mar. 31, 2024
Promissory Notes – Related Parties [Abstract]
PROMISSORY NOTES – RELATED PARTIES	NOTE 6. PROMISSORY NOTES – RELATED PARTIES   As of March 31, 2024, and June 30, 2023, the balance outstanding under promissory notes - related parties was $51,415 and $50,380, respectively. The balances at March 31, 2024 and June 30, 2023 included accrued interest of $1,035 and $270, respectively.   We entered into a Promissory Note (“Note 1”) with Legacy Technology Holdings, Inc. for $9,000 due on demand for advances totaling $9,000 made in November 2022. Note 1 incurred no interest unless it defaults after demand and thereafter at 12% per annum. It is unsecured. Our directors, Calvin D. Smiley, Sr. and Redgie Green are also directors of Legacy Technology Holdings, Inc. and Mr. Green is the CEO/President of Legacy Technology Holdings, Inc.   Effective February 23, 2023, Note 1 with Legacy Technology Holdings, Inc. was amended such that, commencing January 1, 2023, the Note incurred interest of 6% per year, and was assigned a maturity date of August 31, 2023.   Effective March 24, 2023, Note 1 was assigned from Legacy Technology Holdings, Inc. to Perigee Holdings, Inc. whose former directors were Calvin D. Smiley, Sr. and Redgie Green.   Note 1 went into default on August 31, 2023. Interest at a default rate of 18% is accruing on Note 1 subsequent to its default.   We also entered into a further Promissory Note (“Note 2”) in the amount of $41,110 with Michael A Littman, an affiliate of our principal shareholder, Michael A Littman Atty Defined Benefit Plan in respect of funds he had previously advance to us. Note 2 is due on demand and bears no interest unless demand is made and then the default rate is 12% per annum. It is unsecured.

v3.24.1.1.u2

Commitments & Contingencies	9 Months Ended
	Mar. 31, 2024
Commitments & Contingencies [Abstract]
COMMITMENTS & CONTINGENCIES	NOTE 7. COMMITMENTS & CONTINGENCIES   Legal Proceedings   We were not subject to any legal proceedings during the three and nine-month periods ended March 31, 2024 and 2023, and, to the best of our knowledge, no legal proceedings are pending or threatened.   Contractual Obligations   We are not party to any contractual obligations at this time.

v3.24.1.1.u2

Shareholders' Deficit	9 Months Ended
	Mar. 31, 2024
Shareholders' Deficit [Abstract]
SHAREHOLDERS’ DEFICIT	NOTE 8. SHAREHOLDERS’ DEFICIT   Common Stock   As of March 31, 2024, we were authorized to issue 500,000,000 shares of common stock with a par value of $0.0001.   No shares of common stock were issued during the three and nine-month periods ended March 31, 2024 and 2023.   As of March 31, 2024 and June 30, 2023, 1,697,200 shares of common stock were issued and outstanding.   Warrants   No warrants were issued or outstanding during the three and nine-month periods ended March 31, 2024 and 2023.   Stock Options   We currently have no stock option plan.   No stock options were issued or outstanding during the three and nine-month periods ended March 31, 2024 and 2023.

v3.24.1.1.u2

Subsequent Events	9 Months Ended
	Mar. 31, 2024
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 9. SUBSEQUENT EVENTS   The Company evaluated subsequent events after March 31, 2024, in accordance with FASB ASC 855 Subsequent Events, through the date of the issuance of these financial statements and has determined there have been no subsequent event for which disclosure is required.

v3.24.1.1.u2

Pay vs Performance Disclosure - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ (5,867)	$ (10,479)	$ (32,139)	$ (27,537)

v3.24.1.1.u2

Insider Trading Arrangements	3 Months Ended
	Mar. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

v3.24.1.1.u2

Accounting Policies, by Policy (Policies)	9 Months Ended
	Mar. 31, 2024
Summary of Significant Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation This summary of significant accounting policies is presented to assist in the understanding of financial statements. These policies conform to GAAP and have been consistently applied. The Company has selected June 30 as its financial year end.
Interim Financial Statements	Interim Financial Statements The accompanying unaudited interim condensed financial statements have been prepared in accordance with GAAP for interim financial information in accordance with Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The accompanying condensed financial statements have been prepared by the Company without audit. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations, changes in shareholders’ deficit and cash flows as of March 31, 2024 and for the related periods presented, have been included. The results for the three- and nine-months period ended March 31, 2024 are not necessarily indicative of the results of operations for the full year. These financial statements and related footnotes should be read in conjunction with the financial statements and footnotes thereto for the years ended June 30, 2023 and 2022 included in our Form 10-12G/A filed on October 30, 2023.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents: We maintain cash balances in a non-interest-bearing account that currently does not exceed federally insured limits. For the purpose of the statements of cash flows, all highly liquid investments with a maturity of three months or less are considered to be cash equivalents. As of March 31, 2024, and June 30, 2023, our cash balances were $132 and $325 respectively.
Fair Value Measurements	Fair Value Measurements: ASC Topic 820, Fair Value Measurements and Disclosures ("ASC 820"), provides a comprehensive framework for measuring fair value and expands disclosures which are required about fair value measurements. Specifically, ASC 820 sets forth a definition of fair value and establishes a hierarchy prioritizing the inputs to valuation techniques, giving the highest priority to quoted prices in active markets for identical assets and liabilities and the lowest priority to unobservable value inputs. ASC 820 defines the hierarchy as follows: Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reported date. The types of assets and liabilities included in Level 1 are highly liquid and actively traded instruments with quoted prices, such as equities listed on the New York Stock Exchange. Level 2 – Pricing inputs are other than quoted prices in active markets but are either directly or indirectly observable as of the reported date. The types of assets and liabilities in Level 2 are typically either comparable to actively traded securities or contracts or priced with models using highly observable inputs. Level 3 – Significant inputs to pricing that are unobservable as of the reporting date. The types of assets and liabilities included in Level 3 are those with inputs requiring significant management judgment or estimation, such as complex and subjective models and forecasts used to determine the fair value of financial transmission rights. Our financial instruments consist of our prepaid expenses, accounts payable and accruals, loan payable- related party and promissory note- related party. The carrying amount of our prepaid expenses, accounts payable and accruals, loan payable- related party and promissory note- related party approximates their fair values because of the short-term maturities of these instruments.
Related Party Transactions	Related Party Transactions: A related party is generally defined as (i) any person that holds 10% or more of our membership interests including such person's immediate families, (ii) our management, (iii) someone that directly or indirectly controls, is controlled by or is under common control with us, (iv) any person who is or was (since the beginning of the last fiscal year for which the Company has filed an Annual Report on Form 10-K and proxy statement, even if such person does not presently serve in that role) an executive officer, director or nominee for director of the Company, or (v) anyone who can significantly influence our financial and operating decisions. A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties. See Notes 5 and 6 below for details of related party transactions in the period presented.
Leases	Leases: We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) as assets, operating lease non-current liabilities, and operating lease current liabilities in our balance sheet. Finance leases are property and equipment, other current liabilities, and other non-current liabilities in the balance sheet. ROU assets represent the right to use an asset for the lease term and lease liability represent the obligation to make lease payment arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over lease term. As most of the leases doesn’t provide an implicit rate. We generally use the incremental borrowing rate on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. The operating ROU asset also includes any lease payments made and excludes lease incentives. Lease expense for lease payment is recognized on a straight-line basis over lease term. The Company was not party to any lease transaction during the three and nine-month periods ended March 31, 2024 and 2023.
Income Taxes	Income Taxes: The provision for income taxes is computed using the asset and liability method, under which deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating losses and tax credit carryforwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates that apply to taxable income in effect for the years in which those tax assets are expected to be realized or settled. We record a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.
Uncertain Tax Positions	Uncertain Tax Positions: We evaluate tax positions in a two-step process. We first determine whether it is more likely than not that a tax position will be sustained upon examination, based on the technical merits of the position. If a tax position meets the more-likely-than-not recognition threshold, it is then measured to determine the amount of benefit to recognize in the financial statements. The tax position is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement. We classify gross interest and penalties and unrecognized tax benefits that are not expected to result in payment or receipt of cash within one year as long-term liabilities in the financial statements.
Revenue Recognition	Revenue Recognition: Revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements: Step 1: Identify the contract(s) with customers. Step 2: Identify the performance obligations in the contract. Step 3: Determine the transaction price. Step 4: Allocate the transaction price to performance obligations. Step 5: Recognize revenue when the entity satisfies a performance obligation. As the Company had no business operations during the three and nine-month periods ended March 31, 2024 and 2023, we have not identified specific planned revenue streams. During the three and nine-month periods ended March 31, 2024 and 2023, we did not recognize any revenue.
Advertising Costs	Advertising Costs: We expense advertising costs when advertisements occur. No advertising costs were incurred during the three and nine-month periods ended March 31, 2024 and 2023.
Stock-Based Compensation	Stock-Based Compensation: The cost of equity instruments issued to employees and non-employees in return for goods and services is measured by the grant date fair value of the equity instruments issued in accordance with ASC 718, Compensation – Stock Compensation. The related expense is recognized as services are rendered or vesting periods elapse.
Net Loss per Share Calculation	Net Loss per Share Calculation: Basic earnings (loss) per common share ("EPS") is computed by dividing net income (loss) available to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings (loss) per share is computed by dividing net income (loss) by the weighted average shares outstanding, assuming all dilutive potential common shares were issued. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive. No potentially dilutive debt or equity instruments were issued or outstanding during the three and nine-month periods ended March 31, 2024 and 2023.
Recently Accounting Pronouncements	Recently Accounting Pronouncements: We have reviewed all the recently issued, but not yet effective, accounting pronouncements and do not believe any of these pronouncements will have a material impact on our financial statements.

v3.24.1.1.u2

Nature of Operations (Details) - USD ($)		9 Months Ended
	Jun. 28, 2021	Mar. 31, 2024	Jun. 30, 2023
Nature of Operations [Abstract]
Sale of subsidiary issued share capital percentage	100.00%
Cash	$ 1,000
Split shares	50,000
Assets and outstanding liabilities	$ 1,130,842
Reverse and forward stock splits, description		Effective May 13, 2021, we completed:   - a reverse stock split of our outstanding common stock, $0.0001 par value, on a one (1) post-split share for eight thousand (8,000) pre-split shares basis, and subsequently   - a forward stock split of our post reverse split outstanding common stock, $0.0001 par value, on a one hundred (100) post-split shares for one (1) pre-split share basis. As a result of the 8,000: 1 reverse stock split described above, the number of issued and outstanding shares of the Company’s common stock was reduced from 123,224,444 to 15,403. No fractional shares were issued in connection with the reverse stock split. Instead, a holder of record of common stock who would otherwise be entitled to a fraction of a share was, in lieu thereof, entitled to receive a whole share of common stock. Consequently 1,069 additional shares were issued in respect of fractional shares and therefore a total of 16,472 shares of common stock were issued and outstanding after the reverse split.As a result of 1:100 forward stock split described above, the number of issued and outstanding shares of the Company’s common stock increased from 16,472 to 1,647,200.
Common stock, shares outstanding		1,697,200	1,697,200

v3.24.1.1.u2

Going Concern (Details) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023	Jun. 30, 2023
Going Concern [Abstract]
NET LOSS	$ (5,867)	$ (10,479)	$ (32,139)	$ (27,537)
Accumulated deficit	$ (17,797,107)		$ (17,797,107)		$ (17,764,968)

v3.24.1.1.u2

Summary of Significant Accounting Policies (Details) - USD ($)	9 Months Ended
	Mar. 31, 2024	Jun. 30, 2023
Summary of Significant Accounting Policies [Line Items]
Cash	$ 132	$ 325
Tax percentage	50.00%
Related Party Transactions [Member]
Summary of Significant Accounting Policies [Line Items]
Membership interests	10.00%

v3.24.1.1.u2

Accounts Payable and Accruals (Details) - USD ($)	9 Months Ended	12 Months Ended
	Mar. 31, 2024	Jun. 30, 2023
Accounts Payable and Accruals [Line Items]
Accounts payable and accrued expenses	$ 47,183	$ 33,912
Accounting fee	6,450	4,650
Audit fees	5,000
Related Party [Member]
Accounts Payable and Accruals [Line Items]
Due to related party	$ 35,733	$ 29,262

v3.24.1.1.u2

Loan Payable – Related Party (Details) - USD ($)	9 Months Ended
	Mar. 31, 2024	Jun. 30, 2023
Loan Payable – Related Party [Line Items]
Principal shareholder, advance	$ 17,640
Related Party [Member]
Loan Payable – Related Party [Line Items]
Loan payable - related party	$ 25,399	$ 7,759

v3.24.1.1.u2

Promissory Notes – Related Parties (Details) - USD ($)	Feb. 23, 2023	Mar. 31, 2024	Aug. 31, 2023	Jun. 30, 2023	Nov. 30, 2022
Promissory Notes – Related Parties [Line Items]
Accrued interest		$ 1,035		$ 270
Related Party [Member]
Promissory Notes – Related Parties [Line Items]
Note payable related party		51,415		$ 50,380
Legacy Technology Holdings, Inc. [Member]
Promissory Notes – Related Parties [Line Items]
Due amount					$ 9,000
Michael A Littman [Member]
Promissory Notes – Related Parties [Line Items]
Due amount		$ 41,110
Promissory note [Member]
Promissory Notes – Related Parties [Line Items]
Interest rate	6.00%	12.00%
Maturity date	Aug. 31, 2023
Interest default rate			18.00%
Promissory note [Member] | Legacy Technology Holdings, Inc. [Member]
Promissory Notes – Related Parties [Line Items]
Due amount					$ 9,000
Interest rate		12.00%

v3.24.1.1.u2

Shareholders' Deficit (Details) - $ / shares	Mar. 31, 2024	Jun. 30, 2023
Shareholders' Deficit [Abstract]
Common stock, shares authorized	500,000,000	500,000,000
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares issued	1,697,200	1,697,200
Common stock, shares outstanding	1,697,200	1,697,200

null

---